OnCare launches cancer treatment centre in Bengaluru

Bengaluru now has a new cancer treatment centre launched by OnCare, aiming to bring accessible, affordable, and patient-friendly oncology services to the region. Following success in Delhi-NCR, the facility offers comprehensive care including chemotherapy, immunotherapy, and supportive services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4oBSebW
via IFTTT

Read More

Fortis Healthcare inks pact with Dion Group for 300-bed hospital in Cuttack

Fortis Healthcare is set to manage and operate a new 300-bed multi-specialty hospital in Cuttack, Odisha, a project valued at Rs 600 crore. Developed by Dion Group, the facility aims to significantly enhance access to advanced tertiary care for residents of Cuttack, Bhubaneswar, and surrounding areas. This collaboration merges Fortis's extensive healthcare expertise with Dion's infrastructure development vision, promising quality medical services closer to home.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mTuJNxy
via IFTTT

Read More

Sun Pharma secures relief in 'Pantocid' trademark dispute

Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/j2dpVz7
via IFTTT

Read More

Syngene International MD & CEO Peter Bains resigns

Bains has resigned from the position of MD & CEO with effect from the close of business hours on June 30, Syngene International said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YdApZaN
via IFTTT

Read More

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7sBNd9h
via IFTTT

Read More

New rules simplify drug launches, reduce manufacturer liability for overcharging

New rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can seek varied prices for drug variants based on packaging and dosage, fostering flexibility. Overcharging liability is now limited to specific distributors if manufacturers prove compliance, easing burdens for many firms. Stricter record-keeping for seven years is also mandated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ciaZRXt
via IFTTT

Read More

Shantha Biologics to make injectable drug cartridges for Novo Nordisk

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad facility. This partnership highlights India's growing role in advanced pharmaceutical manufacturing, particularly for high-demand diabetes and obesity therapies. Shantha's FDA-approved, automated fill-finish lines will produce these critical components, underscoring the company's expanding capabilities in contract manufacturing for biologics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eqmNj5D
via IFTTT

Read More